PACIFIC BIOSCIENCES OF CALIF (PACB) Stock Income Statement
NASDAQ:PACB - Nasdaq - US69404D1081 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 154.01M | 200.52M | 128.30M | 130.50M | 78.90M | |||
| Cost Of Goods | 115.73M | 144.31M | 75.60M | 71.70M | 46.30M | |||
| Gross Profit | 38.28M | 56.22M | 52.70M | 58.90M | 32.60M | |||
| Operating Expenses | 327.10M | 378.20M | 356.20M | 238.10M | 137.00M | |||
| Research and Development | 134.92M | 187.17M | 193.00M | 112.90M | 64.20M | |||
| Selling, General, and Administrative Expenses | 175.02M | 169.82M | 160.90M | 124.10M | 72.80M | |||
| Operating Income | -288.81M | -321.99M | -303.50M | -179.30M | -104.40M | |||
| Interest Income/Expense | -13.41M | -14.34M | -14.70M | -12.50M | -300.00K | |||
| Other Income/Expense | 23.78M | 32.68M | 7.60M | 100.00K | 2.10M | |||
| Non Recurring Items | -29.89M | -14.51M | -3.70M | -83.10M | 132.00M | |||
| Income Before Taxes | -308.33M | -318.16M | -314.20M | -274.90M | 29.40M | |||
| Income Tax | 316.00K | -11.42M | 0.00 | -93.60M | N/A | |||
| Net Income | -308.65M | -306.74M | -314.20M | -181.20M | 29.40M | |||
| EBITDA | N/A | -302.26M | -293.11M | -171.72M | -97.97M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.12 | -1.21 | -1.40 | -0.89 | 0.17 | |||
| Non GAAP EPS | -0.64 | -1.21 | -1.40 | -1.20 | -0.13 | |||
| Statistics | ||||||||
| Gross Profit Margin | 24.85% | 28.03% | 41.08% | 45.13% | 41.32% | |||
| Profit Margin | -200.40% | -152.97% | -244.89% | -138.85% | 37.26% | |||
| Operating Profit Margin | -187.53% | -160.58% | -236.55% | -137.39% | -132.32% | |||
All data in USD